Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
WY29L43Ry47BVXBL